Floatz logo

Acthar Gel

Neurotrophic Keratitis

Toyos ClinicPhase 4 / ApprovedActive
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Neurotrophic Keratitis cohort.

Asset / SponsorPhaseRating
Acthar
Toyos Clinic
Phase 4CCC

Same molecule, other indications

Acthar Gel is also rated in:

Dry EyeDormant
B
Indicative ·
60 / 100
View asset →
Multiple Sclerosis, Relapsing-RemittingDormant
B
Indicative ·
59 / 100
View asset →
Autoimmune DiseasesDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →